Works matching IS 15257304 AND DT 2021 AND VI 22 AND IP 3


Results: 41
    1

    Table of Contents.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. A5,A25, doi. 10.1016/S1525-7304(21)00082-6
    Publication type:
    Article
    2

    Editorial Board.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. A4, doi. 10.1016/S1525-7304(21)00081-4
    Publication type:
    Article
    3
    4
    5
    6

    Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
    By:
    • Owonikoko, Taofeek K.;
    • Redman, Mary W.;
    • Byers, Lauren A.;
    • Hirsch, Fred R.;
    • Mack, Philip C.;
    • Schwartz, Lawrence H.;
    • Bradley, Jeffrey D.;
    • Stinchcombe, Thomas E.;
    • Leighl, Natasha B.;
    • Al Baghdadi, Tareq;
    • Lara, Primo;
    • Miao, Jieling;
    • Kelly, Karen;
    • Ramalingam, Suresh S.;
    • Herbst, Roy S.;
    • Papadimitrakopoulou, Vassiliki;
    • Gandara, David R.
    Publication type:
    Article
    7

    Recent Advances in the Management of Typical and Atypical Lung Carcinoids.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. 161, doi. 10.1016/j.cllc.2020.12.004
    By:
    • Prinzi, Natalie;
    • Rossi, Roberta Elisa;
    • Proto, Claudia;
    • Leuzzi, Giovanni;
    • Raimondi, Alessandra;
    • Torchio, Martina;
    • Milione, Massimo;
    • Corti, Francesca;
    • Colombo, Elena;
    • Prisciandaro, Michele;
    • Cascella, Tommaso;
    • Spreafico, Carlo;
    • Beninato, Teresa;
    • Coppa, Jorgelina;
    • Lo Russo, Giuseppe;
    • Di Bartolomeo, Maria;
    • de Braud, Filippo;
    • Pusceddu, Sara
    Publication type:
    Article
    8
    9

    A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. 170, doi. 10.1016/j.cllc.2020.09.013
    By:
    • Waqar, Saiama N.;
    • Redman, Mary W.;
    • Arnold, Susanne M.;
    • Hirsch, Fred R.;
    • Mack, Philip C.;
    • Schwartz, Lawrence H.;
    • Gandara, David R.;
    • Stinchcombe, Thomas E.;
    • Leighl, Natasha B.;
    • Ramalingam, Suresh S.;
    • Tanna, Saloni H.;
    • Raddin, Ryan S.;
    • Minichiello, Katherine;
    • Bradley, Jeffrey D.;
    • Kelly, Karen;
    • Herbst, Roy S.;
    • Papadimitrakopoulou, Vassiliki A.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. e415, doi. 10.1016/j.cllc.2020.06.003
    By:
    • Behrens, Carmen;
    • Rocha, Pedro;
    • Parra, Edwin R.;
    • Feng, Lei;
    • Rodriguez-Canales, Jaime;
    • Solis, Luisa M.;
    • Mino, Barbara;
    • Zhang, Jianjun;
    • Gibbons, Don L.;
    • Sepesi, Boris;
    • Rice, David;
    • Heymach, John V.;
    • Moran, Cesar;
    • Creighton, Chad J.;
    • Lee, J. Jack;
    • Kadara, Humam;
    • Wistuba, Ignacio I.
    Publication type:
    Article
    26

    Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. 210, doi. 10.1016/j.cllc.2020.06.002
    By:
    • Patel, Akash;
    • Roshkovan, Leonid;
    • McNulty, Sally;
    • Alley, Evan;
    • Torigian, Drew A.;
    • Nachiappan, Arun C.;
    • Galperin-Aizenberg, Maya;
    • Barbosa, Eduardo M.;
    • DiRienzi, Joseph;
    • Berger, Ian;
    • Khalid, Urooj;
    • Haas, Andrew R.;
    • Singhal, Sunil;
    • Wileyto, E. Paul;
    • Cengel, Keith A.;
    • Katz, Sharyn I.
    Publication type:
    Article
    27
    28
    29

    Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. e379, doi. 10.1016/j.cllc.2020.05.028
    By:
    • Sehgal, Kartik;
    • Bulumulle, Anushi;
    • Brody, Heather;
    • Gill, Ritu R.;
    • Macherla, Shravanti;
    • Qilleri, Aleksandra;
    • McDonald, Danielle C.;
    • Cherry, Cynthia R.;
    • Shea, Meghan;
    • Huberman, Mark S.;
    • VanderLaan, Paul A.;
    • Weiss, Glen J.;
    • Walker, Paul R.;
    • Costa, Daniel B.;
    • Rangachari, Deepa
    Publication type:
    Article
    30
    31
    32

    Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 3, p. e342, doi. 10.1016/j.cllc.2020.05.024
    By:
    • Elbanna, May;
    • Shiue, Kevin;
    • Edwards, Donna;
    • Cerra-Franco, Alberto;
    • Agrawal, Namita;
    • Hinton, Jason;
    • Mereniuk, Todd;
    • Huang, Christina;
    • Ryan, Joshua L.;
    • Smith, Jessica;
    • Aaron, Vasantha D.;
    • Burney, Heather;
    • Zang, Yong;
    • Holmes, Jordan;
    • Langer, Mark;
    • Zellars, Richard;
    • Lautenschlaeger, Tim
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41